Dublin, Jan. 11, 2017 -- Research and Markets has announced the addition of the "Why is FDA at my facility, and what do I do during an inspection?: 2-day In-person Seminar" conference to their offering.
This two day course will prepare firms for a quick, productive, and efficient FDA inspection. Included are segments on FDA Law, how to prepare for the inspection, how to prepare your subject matter experts (SME's) to respond properly, and how to respond to an FDA 483 or Warning Letter. Case Studies and Templates are included.
This course begins with a high level discussion about why FDA conducts inspections and the sanctions available to FDA for those companies who choose not to comply with FDA requirements. Next, we cover what to expect during the inspection, including how to communicate with the investigators, run your front and back rooms, and present documents and records.
We cover do's and don'ts, choosing your core inspection team, facilitators, Subject Matter Experts (SME's), runners and scribes. We provide tips for Executive Management/CEO's, Production area staff, Reception Area staff and what each group needs to know during an inspection. The session includes real life inspection scenarios/case studies. Participants are given real life FDA inspection scenarios and are asked to discuss how they would handle each situation. Feedback is given on how to best handle each situation and scenario. This is one of our most popular training sessions!
Agenda:
Day One (8:30 AM - 5:00 PM)
Registration Process: 8:30 AM - 9:00 AM
Session Start Time: 9:00 AM
FDA Law and Inspection Training
1. FDA Management and General Training
a. Legal Obligations
b. Management Responsibility from FDA's view
2. Front Room Back Room
a. Your FDA Inspection Team
b. FDA Inspection SOP
c. Front Room/Back Room
d. Putting it all together
Day Two (8:30 AM - 4:30 PM) SME training, 483/Warning Letter Response
3. SME Training
a. Basic Ground Rules for everyone
b. Role of the SME
c. FDA Interviews
d. How to get the best out of the inspection
e. Say NO to
f. Do's and Don'ts
4. Replying to 483s and Warning Letters
a. General Points to Consider
b. The Response
c. Templates
d. Let's not forget
e. When and How to do updates
Key Topics Covered:
Day One (8:30 AM - 5:00 PM)
Registration Process: 8:30 AM - 9:00 AM
Session Start Time: 9:00 AM
FDA Law and Inspection Training
1. FDA Management and General Training
a. Legal Obligations
b. Management Responsibility from FDA's view
2. Front Room Back Room
a. Your FDA Inspection Team
b. FDA Inspection SOP
c. Front Room/Back Room
d. Putting it all together
Day Two (8:30 AM - 4:30 PM) SME training, 483/Warning Letter Response
3. SME Training
a. Basic Ground Rules for everyone
b. Role of the SME
c. FDA Interviews
d. How to get the best out of the inspection
e. Say NO to
f. Do's and Don'ts
4. Replying to 483s and Warning Letters
a. General Points to Consider
b. The Response
c. Templates
d. Let's not forget
e. When and How to do updates
For more information about this conference visit http://www.researchandmarkets.com/research/x52vf6/why_is_fda_at_my
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Business


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 



